A Biopharma Pivot Story With Compugen's Dr. Anat Cohen-Dayag
Source: Bioprocess Online
![20_12_BPO_BusBiotech_Social_ep36 20_12_BPO_BusBiotech_Social_ep36](https://vertassets.blob.core.windows.net/image/bebca771/bebca771-a4aa-443e-bd33-e544c9439eb0/375_250-20_12_bpo_busbiotech_social_ep36.png)
Dr. Anat Cohen-Dayag transformed her company from a computational biology service provider to a clinical-stage biopharma with multiple cancer immunotherapy candidates, and she did it in a remarkably short period of time. Listen in as she discusses the human resources, financial, and capital strategies she deployed to build a biotech on the back of computational science, and shares her vision for the future of drug discovery.
access the Podcast!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Bioprocess Online
This website uses cookies to ensure you get the best experience on our website. Learn more